Endeavor

Clinical Trial Offers Hope for Mesothelioma Patients

Chemoperfusion therapy has shown to increase survival and quality of life

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

Melanoma Immunotherapy Offers Hope for Lung Cancer

Patients’ own magnified army of T cells used to treat non-small cell lung cancer

Clinical Trials and COVID-19

Majority of Moffitt patients receiving investigational therapies still on track

Repurposing Drugs to Fight COVID-19

World Health Organization launches global trials on four possible treatments

In the Eye of the COVID-19 Storm

How yearly hurricane planning helped Moffitt be prepared for the pandemic

Innovative Trial Tackles Early Stage Breast Cancer

Immunotherapy plus chemotherapy shows promising results for certain early stage breast cancers

Can Gene Editing Improve Cellular Immunotherapy?

New study suggests CRISPR edited cells can be used to enhance T cell receptor therapy

Moffitt Clinical Trials Offer Hope for Cervical Cancer Patients

“I’m living a normal life,” says one trial participant